Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combinations or sequences of targeted agents in CLL: Is the whole greater than the sum of its parts (Aristotle, 360 BC)?
    Editorial

    Yazdy, M. S.; Mato, A. R.; Cheson, B. D.
    Blood (2019)

    Fulltext@MSK | Save
  • Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY
    Journal Article

    Hehlmann, R.; Cortes, J. E.; Zyczynski, T.; Gambacorti-Passerini, C.; Goldberg, S. L.; Mauro, M. J.; Michallet, M.; Simonsson, B.; Williams, L. A.; Gajavelli, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease
    Journal Article

    Litzow, M. R.; Wang, X. V.; Carroll, M. P.; Karp, J. E.; Ketterling, R. P.; Zhang, Y.; Kaufmann, S. H.; Lazarus, H. M.; Luger, S. M.; Paietta, E. M.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Method comparison study of peripheral blood CD34(+) count performed on an Abbott CELL-DYN Sapphire hematology analyzer versus flow cytometry reference procedure (modified ISHAGE)
    Journal Article

    Avecilla, S. T.; Goss, C.; Marionneaux, S. M.; Wright, D. R.; Leiva, T. D.; Tonon, J. A.; Smith, K. M.; Maslak, P.
    Advances in Cell and Gene Therapy (2018)

    Fulltext@MSK | Save
  • Racial, age, and sex disparities in chronic lymphocytic leukemia (CLL) patients treated with novel therapies
    Meeting Abstract

    Thompson, M.; Nabhan, C.; Cheson, B. D.; Allan, J. N.; Barr, P. M.; Skarbnik, A. P.; Jacobs, R.; Ujjani, C. S.; Furman, R. R.; Schuster, S. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study
    Meeting Abstract

    Pollyea, D. A.; Dinardo, C. D.; de Botton, S.; Stein, E.; Roboz, G. J.; Mims, A. S.; Swords, R. T.; Altman, J. K.; Collins, R.; Mannis, G. N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Physicians' documented performance of shared decision-making with chronic lymphocytic leukemia patients
    Meeting Abstract

    Mato, A. R.; Davids, M. S.; Carter, J. D.; Greene, L.; Sapir, T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of patients with MYC-expressing aggressive B cell non-Hodgkin lymphomas who fail two or more lines of therapy
    Meeting Abstract

    Landsburg, D. J.; Nasta, S.; Svoboda, J.; Mato, A. R.; Schuster, S. J.; Sargent, R. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in serum bilirubin during enasidenib treatment in patients with or without UGT1A1 mutations
    Meeting Abstract

    Fathi, A. T.; Dinardo, C. D.; Kline, I.; Tu, N.; Attar, E. C.; Stein, E. M.; de Botton, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia in the BFORE trial: 24-month follow-up
    Meeting Abstract

    Cortes, J. E.; Mauro, M. J.; Deininger, M. W. N.; Chuah, C.; Kim, D. W.; Kota, V.; Lipton, J. H.; Rousselot, P. H.; Milojkovic, D.; Le Coutre, P. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save